15-51683103-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013243.4(SCG3):c.160A>T(p.Ile54Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000428 in 1,610,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_013243.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCG3 | NM_013243.4 | c.160A>T | p.Ile54Phe | missense_variant | 3/12 | ENST00000220478.8 | NP_037375.2 | |
SCG3 | NM_001165257.2 | c.-537A>T | 5_prime_UTR_variant | 2/11 | NP_001158729.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCG3 | ENST00000220478.8 | c.160A>T | p.Ile54Phe | missense_variant | 3/12 | 1 | NM_013243.4 | ENSP00000220478.3 | ||
SCG3 | ENST00000542355.6 | c.-537A>T | 5_prime_UTR_variant | 2/11 | 2 | ENSP00000445205.2 | ||||
SCG3 | ENST00000558709.1 | c.-394A>T | 5_prime_UTR_variant | 2/5 | 2 | ENSP00000452745.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000218 AC: 54AN: 247760Hom.: 0 AF XY: 0.000127 AC XY: 17AN XY: 134230
GnomAD4 exome AF: 0.0000411 AC: 60AN: 1458278Hom.: 0 Cov.: 29 AF XY: 0.0000317 AC XY: 23AN XY: 725688
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 07, 2024 | The c.160A>T (p.I54F) alteration is located in exon 3 (coding exon 3) of the SCG3 gene. This alteration results from a A to T substitution at nucleotide position 160, causing the isoleucine (I) at amino acid position 54 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at